FDANonrulemakingFDA-2026-N-3499

Who commented on this docket

Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments

4 organizations filed 4 public comments on Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments, at the Food and Drug Administration. The comment window closed 82d ago.

Organizations
4
Comments
4
RIN
Comment window
closed 82d ago

Commenters (4)

  • American Academy of Pediatrics (AAP)
    1 filing · confidence 97%
  • Obesity Action Coalitiontrade assoc.
    1 filing · confidence 85%
  • Pfizer Inc.unverified attribution
    1 filing · confidence 70%
  • The Obesity Societytrade assoc.
    1 filing · confidence 85%
View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.